#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Epidemiology and management of thyroid disorders in pregnancy


Authors: A. Skřivánek 1;  M. Lubušký 2,3;  M. Studničková 2 ;  I. Holusková 4;  M. Procházka 2
Authors‘ workplace: G-Centrum Olomouc, vedoucí MUDr. A. Skřivánek 1;  Porodnicko-gynekologická klinika, FN a LF UP, Olomouc, přednosta prof. MUDr. R. Pilka, Ph. D. 2;  Ústav lekařské genetiky a fetální medicíny, FN a LF UP, Olomouc, přednosta prof. MUDr. J. Šantavý, CSc. 3;  Transfuzní oddělení, FN a LF UP, Olomouc, primářka MUDr. D. Galuszková, MBA, Ph. D. 4
Published in: Ceska Gynekol 2013; 78(1): 62-67

Overview

Objective:
Determine the incidence of asymptomatic decrease of thyroid function at pregnant women in the first trimester of pregnancy in the Olomouc region.

Material and methods:
The authors examined461 women in the first trimester of pregnancy. There was measured serum concentrations of thyrotropin (TSH), free thyroxine (FT4) and thyroidperoxidaseantibody (TPOAb).

Results:
TSH concentration > 2.5 mIU/l was in 21% women (96/461). Reduction of FT4 < 9.8 pmol/l was found in 15 of the 96 women screened with a TSH greater than 2.5 mU/l. For women with TSH ≤ 2.5 mU/l, however, was found reduction of the FT4 < 9.8 pmol/l in 11 cases.

TSH concentration > 3 mIU/l was found in 14% women (64/461). Reduction of FT4 < 9.8 pmol/l was found in 13 of the 64 women screened with a TSH greaterthan 3 mU/l.

TSH concentration> 3.5 mIU/l in 10% of women (45/461). Reduction of FT4 <9.8 pmol/l was found in 11 of 45 examined women with TSH greater than 3.5 mU/l.

TSH concentration > 4 mIU/l in 8% of women (35/461). Reduction of FT4 < 9.8 pmol/l was found in 10 of35 examined women with TSH greater than 4 mU/l.

TPOAb was raised over 20 kU/l in 17% of women (78/461).

Conclusions:

Asymptomatic decrease of thyroid function was during direct examination in the first trimester of pregnancy diagnosed at more than 8% of pregnant women. Untreated decreased of thyroid function at mothers may have a negative impact on the course of pregnancy, as well as on fetal development, especially in the psychomotoric area. The presence of TPOAb indicate an increased risk of developing thyroid fictional disorders in pregnancy or postpartum thyroiditis. TSH in pregnancy may be affected by elevated levels of hCG and may slightly decrease because hCG and TSH have a common alpha subunit. Discussed the specific standards for TSH in pregnant and implementation of systematic screening for women in early pregnancy or before planned conception. Perspective, however, we see in tests of thyroid function already in preconception period.

Keywords:
hypothyroidism – pregnancy – thyrotropin – free thyroxine – thyroidperoxidase


Sources

1. Abalovich, M., Nobuyuki, A., Barbour, LA., et al. Clinical Practice Guideline. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Endocrinol Metab, 2007, 92 (8 Suppl), S1–S47.

2. Ashoor, G., Maiz, N., Rotas, M., et al. Maternal thyroid function at 11–13 weeks of gestation and spontaneous preterm delivery. Obstet Gynecol, 2011, 117(2 Pt 1), p. 293–298.

3. Ashoor, G., Maiz, N., Rotas, M., et al. Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia. Prenat Diagn, 2010, 30, 11, p. 1032–1038.

4. Ashoor, G., Maiz, N., Rotas, M., et al. Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death. Thyroid, 2010, 20(9), p. 989–993.

5. Ashoor, G., Rotas, M., Maiz, N., et al. Maternal thyroid function at 11–13 weeks of gestation in women with hypothyroidism treated by thyroxine. Fetal Diagn Ther, 2010, 28, 1, p. 22–27.

6. Ashoor, G., Kametas, NA. Akolekar, R., et al. Maternal thyroid function at 11–13 weeks of gestation. Fetal Diagn Ther, 2010, 27, 3, p. 156–163.

7. Brent, G., Boyle, CA. Introduction. The impact of maternal thyroid diseases on the developing fetus: implications for diagnosis, treatment, and screening. Summary of proceedings, workshop organization, program, and participants. Thyroid, 2005, 15, 1, p. 36–40.

8. Brent, G. The debate over thyroid-function screening in pregnancy. N Engl J Med, 2012, 366, 6, p. 562–563.

9. Casey, BM., Dashe, JS., Spong, CY., et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol, 2007, 109, p. 1129–1135.

10. Casey, BM., Dashe, JS., Wells, CE., et al. Sublinical hyperthyroidism and pregnancy outcome. Obstet Gynecol, 2006, 107, p. 337–341.

11. Dosiou, C., Sanders, GD., Araki, SS., Crapo, LM. Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol, 2008, 158, p. 841–851.

12. Haddow, JE., Knight, GJ., Palomaki, GE., et al. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screening, 2004, 11, p. 170–174.

13. Hauerová, D., Pikner, R., Topolcan, O., et al. Prevalence poruch štítné žlázy u těhotných žen v západočeském regionu ve 2. trimestru těhotenství v roce 2000 – pilotní studie. Vnitř Lék, 2002, 48, s. 629–631.

14. Hauerová, D., Pikner, R.,Topolčan, O., et al. Poruchy štítné žlázy u těhotných 2000–2002. Závěrečná zpráva IGA MZ ČR, NB/6412-3.

15. Horáček, J., Špitálníková, S., Čepková, J., et al. Screening of autoimmune thyroid disease in pregnancy in highland district. In: Endocrine abstracts, European Congress of Endocrinology, Glasgow, UK. Bioscientifica, 2006, p. 881.

16. Jiskra, J., Límanová, Z., Potluková, E., Antošová, M. Význam screeningu tyreopatií u těhotných žen: patofyziologický podklad a praktické aspekty (The importance of screening for thyroid dysfunction during pregnancy: pathophysiological background and practical implications). Čas Lék čes, 2007, 146, 11, p. 827–833.

17. Kořenek, A. Screening poruch štítné žlázy v graviditě a po porodu (Screening of disturbances of thyroid gland during pregnancy and postpartum). Prakt Gyn, 2009, 13, 3, p. 137–140.

18. Lazarus, JH. Thyroid disease in pregnancy and childhood. Minerva Endocrinol, 2005, 30, 2, p. 71–87.

19. Lazarus, JH., Premawardhana, LD. Screening for thyroid disease in pregnancy. J Clin Pathol, 2005, 58, 5, p. 449–452.

20. Lazarus, JH. Thyroid disorders associated with pregnancy: ethiology, diagnosis, and management. Treat Endocrinol, 2005, 4, 1, p. 31–41.

21. Lazarus, JH., Bestwick, JP., Channon, S., et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med, 2012, 366, 6, p. 493–501.

22. Límanová, Z., Laňková, J., Zamrazil, V. Funkce štítné žlázy a těhotenství. Doporučený postup pro praktické lékaře „Funkční poruchy štítné žlázy“. 2008, s. 6.

23. Límanová, Z., Potluková, E. Význam preventivního vyšetření funkce štítné žlázy v graviditě. (Importance of active screening for thyroid disorders in pregnant women.) Čes Gynek, 2007, 11, 3, p. 120–124.

24. Límanová, Z., et al. Štítná žláza. Praha: Galén, 2006, 371 p.

25. O’Leary, PC., Feddema, PH., Michelangeli, VP., et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol, 2006, 64, p. 97–104.

26. Springer, D., Límanová, Z., Zíma, T., Calda, P. Vyšetření funkce štítné žlázy v těhotenství; naše výsledky. (Functional examination of maternal thyroid in pregnancy; our results.) Actual Gyn, 2009, 1, s. 50–54.

27. Springer, D., Zima, T., Limanova, Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol, 2009, 160, 5, p. 791–797.

28. Springer, D., Horáček, J., Hauerová, D., Límanová, Z. Poruchy funkce štítné žlázy v těhotenství – souhrn výsledků nezávislých studií. (Thyroid malfunction in pregnancy.) Čes Gynek, 2007, 72, 6, p. 375–381.

29. Stricker, R., Echenard, M., Eberhart, R., et al. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol, 2007, 157, p. 509–514.

30. Špitálníková, S., Horáček, J., Pěkná, E., et al. Screening thyreopatií v těhotenství. DMEV, 2006, 8, 4, s. 220–225.

Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine

Article was published in

Czech Gynaecology

Issue 1

2013 Issue 1

Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#